Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review

Beth L Abramson1

  • 1Division of Cardiology, Department of Medicine, St. Michael's Hospital and University of Toronto, Faculty of Medicine, Toronto, Ontario, Canada. abramsonb@smh.toronto.on.ca

Insights

Hormone replacement therapy (HRT) shows minimal benefit for preventing cardiac disease in women. Current evidence indicates HRT is not recommended for primary or secondary cardiac disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology

Background:

  • The role of hormone replacement therapy (HRT) in cardiovascular disease (CVD) prevention remains a subject of debate.
  • Epidemiological evidence regarding HRT's impact on primary and secondary CVD prevention requires careful assessment.

Purpose of the Study:

  • To critically evaluate the epidemiological evidence for HRT's role in the primary and secondary prevention of cardiac disease.
  • To determine the current indications for HRT concerning cardiac health.

Main Methods:

  • Systematic review of epidemiological studies.
  • Assessment of evidence for HRT in women with and without established cardiovascular disease.

Main Results:

  • Current studies indicate a very limited role for HRT in women with existing cardiac disease.
  • The benefit of HRT for cardiac prevention in healthy women without vascular disease was previously unclear but is now addressed.

Conclusions:

  • Hormone replacement therapy (HRT) is not indicated for the sole purpose of preventing cardiac disease.
  • Clinical guidelines should reflect the lack of evidence supporting HRT for cardiac prevention.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...